Form 4 for DGX Quest Diagnostics
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001022079-26-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-03 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $207.73 | -526 | 37.6K | -1% | -$109.3K | |
| 2026-03-04 | 2026-03-02 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $204.86 | -288 | 38.1K | -0.8% | -$59.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | S | D | 526 | $207.73 | 37,557 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-02 | F | D | 288 | $204.86 | 38,083 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. |